Cargando…

Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report

Patient: Male, 38-year-old Final Diagnosis: Crohn’s disease • pulmonary tuberculosis Symptoms: Abdominal pain • bloody bowel movements • diarrhea • dry cough • fever • hyporexia • malaise • weight loss Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Challeng...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Douglas Inomata Cardoso, de Oliveira Santos, Bruna Helena, Renosto, Fernanda Lofiego, Watanabe, Erika Mayumi, Herrerias, Giédre Soares Prates, Saad-Hossne, Rogerio, Baima, Julio Pinheiro, Sassaki, Ligia Yukie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483059/ https://www.ncbi.nlm.nih.gov/pubmed/34564689 http://dx.doi.org/10.12659/AJCR.932963

Ejemplares similares

Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
por: Silva, Elen Farinelli de Campos, et al.
Publicado: (2018)

Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review
por: de Aragão, Maria Cecília, et al.
Publicado: (2021)

Clinical and Psychological Factors Associated with Addiction and Compensatory Use of Facebook Among Patients with Inflammatory Bowel Disease: A Cross-Sectional Study
por: Cury, Giovana Signorelli Astolfi, et al.
Publicado: (2022)

Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
por: Takamune, Debora Mayumi, et al.
Publicado: (2022)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study
por: de Souza, Letícia Rodrigues, et al.
Publicado: (2023)

Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn's Disease
por: Rocha, Thiara Barcelos, et al.
Publicado: (2021)

Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
por: Grillo, Thais Gagno, et al.
Publicado: (2021)

Immune Thrombocytopenic Purpura as an Extraintestinal Manifestation in a Patient with Ulcerative Colitis
por: de Medeiros Dutra, Renata, et al.
Publicado: (2022)

Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020)

Inflammatory bowel disease epidemiology in São Paulo State, Brazil
por: Gasparini, Rodrigo Galhardi, et al.
Publicado: (2018)

Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
por: Garate, Ana Lorena Sousa de Vasconcelos, et al.
Publicado: (2021)

Small Intestinal Hemangioma: A Case Report
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2021)

Intestinal complications in patients with Crohn’s disease in the Brazilian public healthcare system between 2011 and 2020
por: Sassaki, Ligia Yukie, et al.
Publicado: (2023)

Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature
por: Grillo, Thais Gagno, et al.
Publicado: (2023)

Modern surgical strategies for perianal Crohn's disease
por: Zabot, Gilmara Pandolfo, et al.
Publicado: (2020)

Intestinal complications in Brazilian patients with ulcerative colitis treated with conventional therapy between 2011 and 2020
por: Martins, Adalberta Lima, et al.
Publicado: (2023)

Endoscopic Postoperative Recurrence Rates in Crohn's Disease in Korea: The Beginning of a New Approach?
por: Kotze, Paulo Gustavo, et al.
Publicado: (2014)

MicroRNA expression in inflammatory bowel disease-associated colorectal cancer
por: Grillo, Thais Gagno, et al.
Publicado: (2021)

Escherichia coli from Crohn’s disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes
por: da Silva Santos, Ana Carolina, et al.
Publicado: (2015)

Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis
por: de Souza, Helton Luis, et al.
Publicado: (2012)

Fecal microbiota transplantation in refractory ulcerative colitis – a case report
por: Moutinho, B. D., et al.
Publicado: (2019)

MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2021)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
por: Fonseca, Ashley, et al.
Publicado: (2021)

Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)
por: Sassaki, Ligia Yukie, et al.
Publicado: (2022)

Effectiveness of Open Fenestration for Autosomal Dominant Polycystic Liver Disease
por: Norcia, Luiz Fernando, et al.
Publicado: (2022)

Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease
por: Kim, Sun, et al.
Publicado: (2021)

Teaching Elliptical Excision Skills to Novice Medical Students: A Randomized Controlled Study Comparing Low- and High-Fidelity Bench Models
por: Denadai, Rafael, et al.
Publicado: (2014)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask
por: Perez de Arce, Edith, et al.
Publicado: (2021)

Remsima (a Tumor Necrosis Factor (TNF) -α Inhibitor) induced hemolysis in a patient with Crohn's disease - Case report
por: AL-Ansari, Rehab Y., et al.
Publicado: (2021)

Herpetic Esophagitis and Eosinophilic Esophagitis: A Potential Association
por: Quera, Rodrigo, et al.
Publicado: (2021)

Simulation-Based Cutaneous Surgical-Skill Training on a Chicken-Skin Bench Model in a Medical Undergraduate Program
por: Denadai, Rafael, et al.
Publicado: (2013)

Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
por: Norcia, Luiz Fernando, et al.
Publicado: (2022)

Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn’s-Like Ileitis in TNF(ΔARE) Mice
por: Chakraborty, Rajrupa, et al.
Publicado: (2021)

Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα)
por: Cao, Brent L, et al.
Publicado: (2018)

Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells
por: Sakamaki, Ippei, et al.
Publicado: (2021)

Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
por: Cassol, Ornella Sari, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5qnteudgf3j3hpi69ngq0i3ece